The rising number of claims reflects increasing awareness among users who have experienced painful and debilitating side effects
Novo's and Lilly's oral obesity drugs may be particularly attractive to seniors, Risinger said
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
Importantly, GLP-1 therapies have not been associated with an increased risk of pancreatitis or thyroid cancer in clinical trials
One is Virta Health, which advertises its nutrition-focused weight management program as "a proven approach for deprescribing GLP-1s when clinically appropriate." A Virta-funded study assessed 154 people with Type 2 diabetes who stopped using GLP-1 medications but continued following Virta's program, concluding that their weight did not significantly increase after a year
The bloating sensation in my abdomen is no longer there, and my digestion is stronger even though my diet remains the same as before